Announcement on the Adjustment of the Collaborative R&D Model for JAK2 Inhibitor Antitumor New Drugs

About this update from Shouyao Holdings Beijing Co. Ltd. Class A

Announcement on the Adjustment of the Collaborative R&D Model for JAK2 Inhibitor Antitumor New Drugs The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shouyao Holdings Beijing Co. Ltd. Class A